Hopkins said that lenacapavir was expected to be reviewed by the U.S. Food and Drug Administration in 2025, with the potential to dramatically reduce HIV infection. "This will be a critical next step ...
China's top drug regulator has recently approved the nation's first stem cell therapy to treat a type of complication ...
A new drug is hugely effective at protecting people from HIV infection and needs to be injected only twice a year.
China's top drug regulator has recently approved the nation's first stem cell therapy to treat a type of complication ...
Nov. 27, 2024 — Recent results from a recent clinical trial indicate that a twice-yearly injection of Lenacapavir offers an overall 96% reduced risk of acquiring ... HIV Latency Reversing ...
A milestone was reached in the fight against HIV/AIDS with the development of Lenacapavir, a new injectable drug that ...
What new medicines are poised to take the leap from breakthrough to approval in 2025? Here’s what to expect this year.
Global partners have supported Africa’s progress in HIV vaccine research and development. Organisations such as the US ...
Due to its innovative mechanism and extended dosing schedule, Lenacapavir has been described as a pathbreaking advancement in ...
3dOpinion
The renaissance of the Notre-Dame Cathedral: A half-decade ago, the world watched in horror as Notre-Dame de Paris burned.
This year we saw more examples of the destructive effort to undermine abortion as a health service. But overreach into health practices was not limited to abortion care.
Wesley Sundquist’s lab laid foundation for development of a highly effective, long-lasting preventive measure against HIV.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback